A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients
A population PK model of enoxaparin was developed in burn patients using real-world data. Model-informed dosing improved early prophylactic target attainment compared with EQ dosing, providing a practical strategy for optimizing enoxaparin prophylaxis in this high-risk population.
Authors
- Venkata Yellepeddi (ORCID: https://orcid.org/0000-0003-3819-9054)
- Mathangi Gopalakrishnan (ORCID: https://orcid.org/0000-0003-2881-9870)
- Ann Marie Prazak (ORCID: https://orcid.org/0000-0002-1271-476X)
- Babajide Shenkoya (ORCID: https://orcid.org/0009-0005-3315-780X)
Institutions
- University of Maryland, Baltimore (US)
- University of Utah (US)
- Spencer Foundation (US)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1002/bcp.70347
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00